XRP News Today: XRP ETF Debut Marks Transition Toward Utility-Focused Digital Assets as Regulators Approve a New Phase
- Canary Capital's XRPC ETF became the first U.S.-listed spot XRP ETF, trading $26M in 30 minutes on Nasdaq. - The launch followed SEC approval via Form 8-A and reflects growing institutional demand for RippleNet's cross-border payment utility. - XRPC outperformed Solana ETF's $56M first-day volume in pre-launch on-chain activity but faces whale profit-taking and mixed technical indicators. - Regulatory clarity post-July 2025 and XRPC's pure spot structure differentiate it from derivative-based XRPR ETFs,
The
XRPC ETF received approval after Canary Capital
The ETF’s robust debut was supported by notable on-chain activity before its launch.
It’s natural to compare XRPC to Bitwise’s BSOL ETF. While XRPC’s $26 million in first 30-minute volume is less than BSOL’s $56 million on its first day, XRPC stands to benefit from XRP’s established role in global payments and its recent regulatory certainty. The SEC’s guidance from July 2025, which
Technical analysis indicates that XRP’s price may experience short-term swings. The asset was trading near $2.46 at launch, consolidating within a downward wedge pattern, with a potential breakout at $2.88
The future performance of the XRPC ETF will hinge on whether demand is fueled by authentic institutional interest or by expectations already factored into the price.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
ALGO experienced a 16.57% quarter-over-quarter decline due to product transitions and fluctuations in the market.
- ALGO fell 16.57% QoQ amid market volatility and product transition challenges at Alargo. - Alargo replaced Akaroid with NHD, achieving 80% YoY sales growth through direct doctor engagement. - AXI's margin optimization doubled contribution per piece despite 60% volume decline from low-margin delistings. - ARCO Pharma's rebranding and scientific training aims to strengthen pharmacist relationships and market position. - Analysts note long-term margin potential but warn of short-term revenue risks from tran
BCH Drops 1.35% Today as Loan Expansion Slows and Profitability Faces Challenges
- BCH fell 1.35% in 24 hours amid weak loan growth and reduced inflation adjustment income, with 60% revenue tied to net interest income. - Institutional holdings rose 12.75% but shares held dropped 3.53%, as Bridge Builder increased exposure while Baillie Gifford cut holdings by 289.93%. - Goldman Sachs maintains Neutral rating with 0.70% upside, while backtesting shows mixed post-earnings performance with limited statistical significance from two data points.
ZEC drops 5.9% over 24 hours as significant institutional funds flow in
- Zcash (ZEC) fell 5.9% in 24 hours amid a 20.64% 7-day drop, but gained 768.62% over one year. - Cypherpunk Technologies acquired 1.25% of ZEC supply via a $58.88M Winklevoss Capital-backed investment, aiming to accumulate 5% total supply. - Tyler Winklevoss positioned Zcash as "encrypted Bitcoin ," emphasizing privacy-driven value transfer and potential to capture Bitcoin's market share. - Technical analysis shows ZEC breaking key support levels with RSI near neutrality, while institutional activity reve
LUNA Drops 2.7% Over 24 Hours as Overall Market Shows Signs of Weakness
- LUNA fell 2.7% in 24 hours to $0.0788, continuing a 12.29% weekly and 15.2% monthly decline. - Technical indicators show bearish momentum, with RSI below key support and MACD in negative territory. - The drop reflects broader market caution and waning investor confidence amid persistent risk-off behavior.